What You Should Know:
- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart and lung disease launches the SENSORA™ Cardiac Disease Detection Platform.
- SENSORA™ currently features AI that objectively identifies structural murmurs, a sign of valvular heart disease, and Care Pathway Analytics software that provides downstream visibility and metrics of the patient journey through the healthcare system.
Eko SENSORA Cardiac Disease Detection
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
Vytalize Health Closes $100M to Support Value-Based Care Transformation
What You Should Know:
- Vytalize Health, a leading risk-bearing provider enablement platform, announced it has closed $100 million in funding led by Enhanced Healthcare Partners and Monroe Capital, with participation from North Coast Ventures.
- Vytalize Health partners with primary care practices for more than 250,000 patients and offers evidence-based recommendations at the point of care. By delivering the right data at the right time in the workflow to physicians and their staff,
Read More
Ambience Healthcare Launches Automated AI Medical Scribe Platform
What You Should Know:
- Ambience Healthcare, an AI company developing technology to supercharge healthcare providers launches its fully automated AI medical scribe, Ambience AutoScribe.
- Already in use by provider organizations across North America, AutoScribe is revolutionizing the way healthcare providers document patient visits.
How AutoScribe Works
AutoScribe comprehensively captures the nuances of each patient story, without the need for a virtual or in-person human scribe.
Read More
Tempus Forms Multi-omics Collaboration With Actuate Therapeutics
What You Should Know:
- Tempus, the $10B artificial intelligence and precision medicine company, announced their first multi-omics collaboration with Actuate Therapeutics, in which datasets of different omic groups – genomics, transcriptomics, epigenomics, and others are combined during analysis to improve research and enable new discoveries, including ones that would have been missed with a single method alone.
- This multi-omics approach is being used by Actuate Therapeutics in support
Read More
Vysioneer & Pfizer Partner on AI-Powered Oncology Clinical Trials
What You Should Know:
- Vysioneer, a provider of applied AI for Oncology, today announced a data-sharing agreement with Pfizer, a global leader in pharmaceuticals. The agreement aims to lay the foundation for the application of AI in oncology clinical trials.
As part of the agreement, Vysioneer gains access to one of Pfizer's oncology clinical trial datasets to apply Vysioneer's advanced machine-learning techniques to facilitate the drug efficacy assessment process, thereby allowing Pfizer
Read More
Aledade Acquires Curia, Adds More Than 450 New Practices
What You Should Know:
- Aledade today announced the acquisition of Curia, a leader in value-based care analytics using practical applications of artificial intelligence (AI) to optimize the targeting of patient care and engagement programs. The acquisition will enhance Aledade’s ability to extract valuable insights from disparate data sources, provide more accurate predictions using past data, and optimize primary care workflows through cutting-edge AI algorithms.
- In addition, the
Read More
Bluestem Health Launches AI-Based Virtual Healthcare Assistant Powered by Mediktor
What You Should Know:
- Nebraska-based Bluestem Health today announced it has launched an AI-based virtual medical assistant powered by Mediktor. This is available for both established and non-established patients to efficiently assess their symptoms online and direct them to the appropriate level of care.
- Mediktor combines AI, Natural Language Processing (NLP) and machine learning technologies for the first clinically validated digital medical assistant, proven in clinical trials with
Read More
Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved
Today, cancer is the second leading cause of death in the United States. Sadly, cancer disparities exist, with racial/ethnic minority, low-income, and uninsured populations suffering the greatest burden. That’s why routine cancer screening is critical to addressing cancer disparities as they have the potential to greatly reduce both incidence and mortality rates. To address this, Federally qualified health centers (FQHCs) are funded by the Health Resources and Services Administration to provide
Read More
From Telemedicine to Complete Virtual Care and Beyond
Telemedicine has helped improve the quality of life of patients in every corner of the world and has been successfully utilized to provide convenient care to people with limited or no access to health services. Today, worldwide digital interconnectivity is growing, enabling telehealth to advance health equity, bring access to care for underserved regions and meet the urgent, primary and behavioral healthcare needs of an exploding global population.
It has been a remarkable journey for the
Read More
Home Healthcare Market is Expected to Reach $340.2B
What You Should Know:
- Home Healthcare market in terms of revenue was estimated to be worth $226 Billion in 2022 and is poised to reach $340.2 billion by 2027, growing at a CAGR of 8.5% from 2022 to 2027 according to a latest report published by MarketsandMarkets™.
- The report reveals growth in this market is mainly driven by rapid growth in the elderly population, and the rising incidence of chronic diseases.
Rising Demand for Home-Health Services & Solutions
The home
Read More
